ICU Medical, Inc.

    Jurisdiction
    United States
    LEI
    5493003NRW7LS2QZRH60
    ISIN
    US44930G1076 (ICUI)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    InsiderPie Expert Score
    53 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. Read full profile

    Fundamentals

    Net revenue
    €2.02B
    Gross margin
    35.8%
    EBIT
    €59.20M
    EBIT margin
    2.9%
    Net income
    -€31.52M
    Net margin
    -1.6%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €1.83B -9.7% €171.81M -645.2%
    €1.87B +2.6% €201.15M +17.1%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Greenberg David C. N/A +1.2K $126.42 +$151.70K
    Jain Vivek Chairman and CEO +22K $112.84 +$2.47M

    Congress transactions

    Name Transaction date Value
    Gilbert Cisneros June 6, 2025 $1.00K–$15.00K
    Josh Gottheimer November 6, 2024 $1.00K–$15.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 8.8K $1.22M -1.2K Sell

    Earnings Calls

    Latest earnings call: May 7, 2024 (Q1 2024)

    Add to watchlist

    Notifications